Combined interferon alfa-2a and cytosine arabinoside as first-line treatment for chronic myeloid leukemia.

Arthur, C K

Combined interferon alfa-2a and cytosine arabinoside as first-line treatment for chronic myeloid leukemia. [electronic resource] - Acta haematologica 1993 - 15-21 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

0001-5792

10.1159/000204580 doi


Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Child
Cytarabine--administration & dosage
Female
Humans
Interferon alpha-2
Interferon-alpha--administration & dosage
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Male
Metaphase
Middle Aged
Polymerase Chain Reaction
Recombinant Proteins